Neurophth Therapeutics Funding: $125M Raised, Series C+

Neurophth Therapeutics funding overview

Neurophth Therapeutics has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C+ announced in April 2020. The round record for Neurophth Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Fosun's InnoStar Venture, Sequoia Capital China, CMG-SDIC Capital, Yangtze River Industry Fund, Wuhan Optical Valley Financial Holding Group, Wuhan Hi-Tech Holding Group and 1 others. 7 distinct backers are named across the disclosed rounds.

Neurophth Therapeutics at a glance

Total raised: $125M
Latest round: Series C+
Latest round date: April 2020
Notable investors: Fosun's InnoStar Venture, Sequoia Capital China, CMG-SDIC Capital, Yangtze River Industry Fund, Wuhan Optical Valley Financial Holding Group, Wuhan Hi-Tech Holding Group, Sunshine Insurance

Frequently asked about Neurophth Therapeutics funding

How much has Neurophth Therapeutics raised?: Neurophth Therapeutics has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Neurophth Therapeutics?: Fosun's InnoStar Venture, Sequoia Capital China, CMG-SDIC Capital, Yangtze River Industry Fund, Wuhan Optical Valley Financial Holding Group, Wuhan Hi-Tech Holding Group are named among the investors backing Neurophth Therapeutics.
What was the latest Neurophth Therapeutics funding round?: The most recent disclosed round is a Series C+, announced in April 2020.
Where is Neurophth Therapeutics based?: No headquarters location is disclosed for Neurophth Therapeutics.
When did Neurophth Therapeutics last raise?: The last disclosed Neurophth Therapeutics round closed in April 2020 at Series C+.

Round data for Neurophth Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Neurophth Therapeutics Funding: $125M Raised, Series C+

Neurophth Therapeutics funding overview

Neurophth Therapeutics at a glance

Frequently asked about Neurophth Therapeutics funding

Companies related to Neurophth Therapeutics (30)

Browse related funding lists (4)